Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia

Indian Journal of Urology

Volumn 25, Issue 3, 2009, Pages 421-423

  Agrawal, S K ^a   Agarwal, M M ^a   Singh, S K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PROSTATE SPECIFIC ANTIGEN;

APOPTOSIS; CATHETER REMOVAL; DRUG COST; EPITHELIUM CELL; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INDWELLING CATHETER; INJECTION; LOWER URINARY TRACT SYMPTOM; MICTURITION; MINIMALLY INVASIVE PROCEDURE; NOTE; OPEN STUDY; PROSTATE HYPERTROPHY; RESIDUAL VOLUME; SMOOTH MUSCLE CONTRACTILITY; SURGICAL RISK; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TREATMENT DURATION; URINE FLOW RATE; URINE RETENTION;

EID: 70349816978     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A. Relief by Botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 2003;62:259-264
2. Chuang YC, Chiang PH, Huang CC, Yoshimura N, Chancellor MB. Botulinum toxin type a improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 2005;66:775-779
3. Chuang YC, Chancellor MB. The application of botulinum toxin in the prostate. J Urol 2006;176:2375-2382
4. Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA. Botox-induced prostatic involution. Prostate 1998;37:44-50
5. Silva J, Silva C, Saraiva L, Silva A, Pinto R, Dinis P, et al. Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement: effect on prostate volume and micturition resumption. Eur Urol 2008;53:153-159